BIOTIME 8-K 10-15-2009

Company

Lineage Cell Therapeutics, Inc.

Filed

October 16, 2009

Period of Report

October 15, 2009

Accession Number

0001140361-09-023354

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →